{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:06:55Z","timestamp":1787612815707,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jpba.2024.116109","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T08:39:29Z","timestamp":1710837569000},"page":"116109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Green innovation in analytical chemistry: A sustainable densitometric HPTLC approach for the distinctive separation and quantification of structurally related abused drugs - tramadol, tapentadol, and venlafaxine - in seized pharmaceutical dosage forms"],"prefix":"10.1016","volume":"243","author":[{"given":"Hala M.","family":"Heneedak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Abdelshakour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled M.","family":"Darwish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia M.","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Saleh","family":"Elgawish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2024.116109_bib1","unstructured":"Global Commission on Drug Policy. TIME TO END PROHIBITION. Youtube; [cited 2022 Sep 3]. Available from: https:\/\/www.youtube.com\/c\/Globa lCommissiononDrugPolicy."},{"issue":"2","key":"10.1016\/j.jpba.2024.116109_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/dta.220","article-title":"Adulterants in illicit drugs: a review of empirical evidence","volume":"3","author":"Cole","year":"2011","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2024.116109_bib3","author":"Pascale","year":"2019","journal-title":"Drug Adulte Eff. Health users: Crit.\u00a0Cal. Rev."},{"key":"10.1016\/j.jpba.2024.116109_bib4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12954-023-00905-8","article-title":"First drug-checking study at an electronic festival and fentanyl detection in the central region of Mexico","volume":"20","author":"Cruz","year":"2023","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.jpba.2024.116109_bib5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2165\/00023210-200115080-00007","article-title":"Venlafaxine extended release: a review of its use in the management of major depression","volume":"15","author":"Wellington","year":"2001","journal-title":"CNS Drugs"},{"issue":"3 Suppl 2","key":"10.1016\/j.jpba.2024.116109_bib6","doi-asserted-by":"crossref","first-page":"37S","DOI":"10.1097\/00004714-199606002-00009","article-title":"Drug-drug interactions involving antidepressants: focus on venlafaxine","volume":"16","author":"Ereshefsky","year":"1996","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpba.2024.116109_bib7","unstructured":"Brunt T. Drug checking as a harm reduction tool for recreational drug users: opportunities and challenges Background paper commissioned by the EMCDDA for Health and social responses to drug problems: a Euro pean guide Drug checking as a harm reduction tool for recreational drug users: opportunities and challenges Dr Tibor Brunt Drug Information and Monitoring System, the Netherlands. 2017."},{"key":"10.1016\/j.jpba.2024.116109_bib8","doi-asserted-by":"crossref","first-page":"700","DOI":"10.3389\/fpsyt.2020.00700","article-title":"New Trends of Substance Abuse during COVID-19 Pandemic: An International Perspective","volume":"11","author":"Zaami","year":"2020","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jpba.2024.116109_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102834","article-title":"Why we should all be more careful in drawing conclusions about how COVID-19 is changing drug markets","volume":"83","author":"Giommoni","year":"2020","journal-title":"Int. J. Drug Policy"},{"issue":"8","key":"10.1016\/j.jpba.2024.116109_bib10","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.3390\/ijms22084000","article-title":"Ultra-High Performance Liquid Chromatography-High Resolution Mass Spectrometry and High-Sensitivity Gas Chromatography-Mass Spectrometry Screening of Classic Drugs and New Psychoactive Substances and Metabolites in Urine of Consumers","volume":"22","author":"Marchei","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.jpba.2024.116109_bib11","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/ejp.1196","article-title":"Comparative pharmacology and toxicology of tramadol and tapentadol","volume":"22","author":"Faria","year":"2018","journal-title":"Eur. J. Pain."},{"key":"10.1016\/j.jpba.2024.116109_bib12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2147\/JPR.S129553","article-title":"Secular trends in opioid prescribing in the USA","volume":"10","author":"Pezalla","year":"2017","journal-title":"J. Pain. Res"},{"key":"10.1016\/j.jpba.2024.116109_bib13","unstructured":"Egypt, Strengthening international cooperation in addressing the non-medical use and abuse, the illicit manufacture and the illicit domestic and international distribution of tramadol, Commission on Narcotic Drugs, Vienna, 2017."},{"key":"10.1016\/j.jpba.2024.116109_bib14","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3109\/10826084.2014.991406","article-title":"Medical and psychiatric effects of long-term dependence on high dose of tramadol","volume":"50","author":"El-Hadidy","year":"2015","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.jpba.2024.116109_bib15","first-page":"64","author":"WHO","year":"2021","journal-title":"Annu. Rep. Int. Narc. Control Board, Chapter III, Anal. World Situat."},{"key":"10.1016\/j.jpba.2024.116109_bib16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jpba.2012.04.020","article-title":"Quantification of tapentadol in canine plasma by HPLC with spectrofluorimetric detection: developement and validation of a new methodology","volume":"67","author":"Giorgi","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116109_bib17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.clinthera.2014.07.005","article-title":"Practical considerations for the use of tapentadol prolonged release for the management of severe chronic pain","volume":"37","author":"S\u00e1nchez del \u00c1guila","year":"2015","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jpba.2024.116109_bib18","unstructured":"WHO, Annual report of International narcotic control board (INCB), Chapter III, Analysis of the world situation, 2018."},{"key":"10.1016\/j.jpba.2024.116109_bib19","first-page":"1261","article-title":"and S. Kamdar, Development and Validation of HPTLC Method for Estimation of Tramadol HCl in Bulk and in Capsule Dosage Form, Int. J. of Pharm Tech","volume":"4","author":"Parva","year":"2012","journal-title":"Research"},{"key":"10.1016\/j.jpba.2024.116109_bib20","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1556\/JPC.24.2011.2.15","article-title":"Stability\u2013indicating HPTLC method for analysis of venlafaxine hydrochloride, and use of the method to study degradation kinetics","volume":"24","author":"Ramesh","year":"2011","journal-title":"J. Planar Chromatogr."},{"key":"10.1016\/j.jpba.2024.116109_bib21","first-page":"136","article-title":"Development and Validation of HPTLC Method for Estimation of Tapentadol Hydrochloride","volume":"2","author":"Roy","year":"2014","journal-title":"Pharma Tutor"},{"key":"10.1016\/j.jpba.2024.116109_bib22","article-title":"HPTLC Analysis and Force Degradation Study of Tapentadol Hydrochloride in Bulk and Its Pharmaceutical Formulation","volume":"15","author":"Asmita","year":"2022","journal-title":"Res. J. Pharm. Technol."},{"key":"10.1016\/j.jpba.2024.116109_bib23","doi-asserted-by":"crossref","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","article-title":"AGREE\u2014Analytical GREEnness Metric Approach and Software","volume":"92","author":"Pena-Pereira","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116109_bib24","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1039\/C9RA07825H","article-title":"Ecofriendly densitometric RP-HPTLC method for determination of rivaroxaban in nanoparticle formulations using green solvents","volume":"10","author":"Alam","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.jpba.2024.116109_bib25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.microc.2019.04.074","article-title":"Green RP-HPLC method for simultaneous determination of moxifloxacin combinations: Investigation of the greenness for the proposed method","volume":"148","author":"Ibrahim","year":"2019","journal-title":"Microchem. J."},{"issue":"2","key":"10.1016\/j.jpba.2024.116109_bib26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/03067319.2018.1430794","article-title":"Activated carbon cloth filled pipette tip for solid phase extraction of nickel(II), lead(II), cadmium(II), copper(II) and cobalt(II) as 1,3,4-thiadiazole-2,5-dithiol chelates for ultra-trace detection by FAAS","volume":"98","author":"Habila","year":"2018","journal-title":"Int. J. Environ. Anal. Chem."},{"issue":"5","key":"10.1016\/j.jpba.2024.116109_bib27","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.arabjc.2018.05.012","article-title":"Application of carbon nanotubes in extraction and chromatographic analysis: A review","volume":"12","author":"ALOthman","year":"2019","journal-title":"Arab. J. Chem."},{"issue":"4","key":"10.1016\/j.jpba.2024.116109_bib28","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.jksus.2020.03.030","article-title":"Development of a sensitive liquid-liquid extraction and ultra-performance liquid chromatography-tandem mass spectrometry method for the analysis of carbaryl residues in fresh vegetables sold in Riyadh","volume":"32","author":"AlFaris","year":"2020","journal-title":"J. King Saud. Univ. -Sci."},{"key":"10.1016\/j.jpba.2024.116109_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2022.133988","article-title":"Green solvent processing: Effect of type of solvent on extraction and quality of protein from dairy and non-dairy expired milk products","volume":"400","author":"Kamal","year":"2023","journal-title":"Food Chem."},{"key":"10.1016\/j.jpba.2024.116109_bib30","series-title":"New Generation Green Solvents for Separation and Preconcentration of Organic and Inorganic Species","first-page":"207","article-title":"Chapter 5 - Type of green solvents used in separation and preconcentration methods","author":"Yilmaz","year":"2020"},{"key":"10.1016\/j.jpba.2024.116109_bib31","doi-asserted-by":"crossref","first-page":"24063","DOI":"10.1039\/c3ra44442b","article-title":"P. D. Morrisona and D. M. Small, Heptane as a less toxic option than hexane for the separation of vitamin E from food products using normal phase HPLC","volume":"3","author":"Buddrick","year":"2013","journal-title":"RSC Adv."},{"key":"10.1016\/j.jpba.2024.116109_bib32","first-page":"32","article-title":"Harmonised tripartite guideline, stability testing of new drug substances and products","author":"Q1A(R2","year":"2003","journal-title":"Int. Conf. Harmon. Tech. Requir. Regist. Pharm. Hum. Use"},{"key":"10.1016\/j.jpba.2024.116109_bib33","series-title":"Dordecht, London, UK","author":"Srivastava","year":"2011"},{"key":"10.1016\/j.jpba.2024.116109_bib34","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1002\/jssc.201901307","article-title":"Fast and efficient immunoaffinity column cleanup and liquid chromatography\u2013tandem mass spectrometry method for the quantitative analysis of aflatoxins in baby food and feeds","volume":"43","author":"Al Faris","year":"2020","journal-title":"J. Sep Sci."},{"key":"10.1016\/j.jpba.2024.116109_bib35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jchromb.2016.07.040","article-title":"Determination of free fatty acids in olive oils by UPHLC\u2013MS","volume":"1031","author":"Wabaidur","year":"2016","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2024.116109_bib36","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1039\/D0AY02169E","article-title":"Comparative study of four greenness assessment tools for selection of greenest analytical method for assay of hyoscine N-butyl bromide","volume":"13","author":"Gamal","year":"2021","journal-title":"Anal. Methods"},{"issue":"15","key":"10.1016\/j.jpba.2024.116109_bib37","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1039\/C6AY00478D","article-title":"Metrics for green analytical chemistry","volume":"8","author":"Tobiszewski","year":"2016","journal-title":"Anal. Methods"},{"issue":"14","key":"10.1016\/j.jpba.2024.116109_bib38","doi-asserted-by":"crossref","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","article-title":"AGREE Analytical GREEnness metric approach and software","volume":"92","author":"Pena-Pereira","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116109_bib39","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.talanta.2018.01.013","article-title":"A new tool for the evaluation of the ana lytical procedure: Green Analytical Procedure Index","volume":"181","author":"P\u0142otka-Wasylka","year":"2018","journal-title":"Talanta"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524001493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524001493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T20:05:29Z","timestamp":1715285129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524001493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":39,"alternative-id":["S0731708524001493"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116109","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Green innovation in analytical chemistry: A sustainable densitometric HPTLC approach for the distinctive separation and quantification of structurally related abused drugs - tramadol, tapentadol, and venlafaxine - in seized pharmaceutical dosage forms","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116109"}}